Clinical trial
Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild…
NCT00403910 · Heart Care Foundation, Other · Completed
Key facts
| NCT number | NCT00403910 |
|---|---|
| Title | Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study |
| Official title | Phase 3 Study Of Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure |
| Lead sponsor | Heart Care Foundation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Canrenone |
| Enrollment | 500 |
| Start date | Sep 1, 2002 |
| Completion | Jul 1, 2006 |
| First posted | Nov 27, 2006 |
| Last update posted | Feb 3, 2021 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: